The estimated Net Worth of John Paul Johnson is at least 8.18 百万$ dollars as of 22 August 2024. Mr. Johnson owns over 44,693 units of Evolent Health Inc stock worth over 5,161,891$ and over the last 5 years he sold EVH stock worth over 1,969,574$. In addition, he makes 1,051,670$ as Chief Financial Officer at Evolent Health Inc.
John has made over 3 trades of the Evolent Health Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 44,693 units of EVH stock worth 1,340,790$ on 22 August 2024.
The largest trade he's ever made was exercising 71,716 units of Evolent Health Inc stock on 2 March 2022 worth over 2,162,237$. On average, John trades about 13,484 units every 90 days since 2020. As of 22 August 2024 he still owns at least 171,207 units of Evolent Health Inc stock.
You can see the complete history of Mr. Johnson stock trades at the bottom of the page.
John Paul Johnson serves as Chief Financial Officer of the Company. He has served as the Chief Financial Officer of New Century Health, a subsidiary of the Company, since March 2019. Mr. Johnson also served as the Senior Vice President of Corporate Performance of the Company from January 2018 until March 2019 and as the Vice President of Corporate Performance from April 2016 until December 2017. Mr. Johnson has been instrumental in driving the Company’s financial strategy and performance. Prior to joining the Company, Mr. Johnson was the Managing Partner at Riverbend Analytics, LLC from December 2015 until April 2016 and the Vice President of Strategy at PSA Healthcare from February 2013 until November 2015.
As the Chief Financial Officer of Evolent Health Inc, the total compensation of John Johnson at Evolent Health Inc is 1,051,670$. There are 6 executives at Evolent Health Inc getting paid more, with Frank Williams having the highest compensation of 4,103,000$.
John Johnson is 35, he's been the Chief Financial Officer of Evolent Health Inc since 2019. There are 20 older and no younger executives at Evolent Health Inc. The oldest executive at Evolent Health Inc is Dr. Norman C. Payson, 72, who is the Advisor.
John's mailing address filed with the SEC is C/O EVOLENT HEALTH, INC., 1812 N. MOORE ST., STE. 1705, ARLINGTON, VA, 22209.
Over the last 9 years, insiders at Evolent Health Inc have traded over 768,852,997$ worth of Evolent Health Inc stock and bought 93,949 units worth 860,849$ . The most active insiders traders include Growth Ii Advisors, Inc.Bon...、Upmc、Group Inc Unitedhealth. On average, Evolent Health Inc executives and independent directors trade stock every 18 days with the average trade being worth of 6,587,353$. The most recent stock trade was executed by Daniel Joseph Mc Carthy on 22 August 2024, trading 34,162 units of EVH stock currently worth 1,070,637$.
our company evolent health supports progressive health care systems lead, build and own the path to value-based care. headquartered in arlington, virginia, we are backed by: the advisory board company (nasdaq: abco), university of pittsburgh medical center health plan, and tpg growth. we integrate the people, processes and technology needed to advance value-based care delivery and innovative payment models. our culture we’ve built a team of dedicated individuals who genuinely enjoy working together. our accessible leadership team cultivates an open-door environment. we take smart risks and when we fail, we fail forward. we respect and encourage commitments outside of work. while we don’t all work the same way or the same hours, we are all dedicated to exceptional results. our benefits treadmill desks, healthy snacks and wellness challenges are just part of our resolve to promote a healthy (and fun!) work environment. we recognize and reward our most valuable asset—our team—wi
Evolent Health Inc executives and other stock owners filed with the SEC include: